Elevance Health elects Deanna Strable-Soethout to Board, effective Nov 1, 2022

Elevance Health, Inc.

Ms. Strable-Soethout is EVP and CFO of Principal Financial Group, a Fortune 500 insurer.
She will serve on the Audit and Governance Committees; qualifies as audit committee financial expert.
Over 70% of Elevance's Board now comprises women or racially/ethnically diverse directors.
Her term runs until the 2023 annual meeting; compensation follows standard non-employee director program.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Deanna Strable-Soethout

Director

ELV · Elevance Health, Inc.

Effective: 2022-11-01
Filed: October 25, 2022, 7:59 PM ET

On October 24, 2022, the Board of Directors (the “Board”) of Elevance Health, Inc. (the “Company”) elected Deanna Strable-Soethout to serve as an independent director effective November 1, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Deanna Strable-Soethout was elected as Director at Elevance Health, Inc..

Action: elected
Role: Director

Exact text from the filing

On October 24, 2022, the Board of Directors (the “Board”) of Elevance Health, Inc. (the “Company”) elected Deanna Strable-Soethout to serve as an independent director effective November 1, 2022

View on SEC.gov

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-267819

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.